You have 9 free searches left this month | for more free features.

City

Celebration (1)

Detroit (1)

Durham (1)

Condition

Metastatic NSCLC (1)

Non Small Cell Lung Cancer (1)

Non-small Cell Lung Cancer (1)

Recurrent Non Small Cell Lung Cancer (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Edward Patz (1)

Jeffrey Clarke (1)

Collaborator

Grid Therapeutics (1)

Merck Sharp & Dohme LLC (1)

Intervention

gt103 (2)

pembrolizumab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

gt103

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Non Small Cell Lung Cancer, Metastatic NSCLC, Recurrent Non Small Cell Lung Cancer Trial (Pembrolizumab, GT103)

Not yet recruiting

Non Small Cell Lung Cancer
+2 more

Pembrolizumab
GT103

(no location specified)

Jan 12, 2023

NSCLC Trial in Celebration, Detroit, Durham (GT103)

Recruiting

Non-small Cell Lung Cancer

GT103

Celebration, Florida
+2 more

Nov 22, 2022